Join us Dec. 1-3 in Nashville for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
D+ Research: Marketers express revenue optimism for 2026 holiday season despite economic pressures
Marketers expect their 2026 holiday revenue to increase 1% to 31% or more in comparison to their 2025 holiday revenue.
Mattel brings Barbie, Hot Wheels to TikTok Shop
Mattel’s TikTok Shop store debuts this week with roughly 20 products across Barbie, Hot Wheels, Fisher-Price and Monster High properties.
Future of Marketing Briefing: Inside Guinness’ go-slow approach to creators
The case for doing less with creators, according to Guinness